Čájehuvvojit 1 - 4 oktiibuot 4 bohtosis ohcui "trematode"', ohcanáigi: 0,01s Aiddostahte ozu
  1. 1
    Table 1_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx

    Table 1_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx Dahkki Javier Sánchez-Montejo (22681769)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Table 2_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx

    Table 2_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx Dahkki Javier Sánchez-Montejo (22681769)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Data Sheet 1_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx

    Data Sheet 1_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx Dahkki Javier Sánchez-Montejo (22681769)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Table 3_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx

    Table 3_Harnessing mRNA technology against Fasciola hepatica: Immunological insights from a fatty acid binding protein vaccine.docx Dahkki Javier Sánchez-Montejo (22681769)

    Almmustuhtton 2025
    Fáttát:
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: